News Tag Archive
Fresenius Kabi
Read drug shortage and pharmaceutical supply articles that mention Fresenius Kabi, including procurement context and related market updates.
3 articles tagged for Fresenius Kabi
Browse coverage for this manufacturers archive.
July 8, 2026
Omnipaque (Iohexol) and Contrast Media Supply Update: What Healthcare Buyers Need to Know
Updated October 2026. Omnipaque (Iohexol) is not on FDA's shortage list, but open recall entries, a GE HealthCare capacity remark, Guerbet's Raleigh batch-release work and Hengrui discontinuations are worth tracking. No public source gives NDC-level availability.
June 24, 2026
Tocilizumab (Tyenne) Shortage Update: What Healthcare Buyers Need to Know
Updated October 2026. FDA does not list tocilizumab, but the American College of Rheumatology reports a Tyenne shortage as of July 2026, alongside a Class I recall of one 400 mg lot and shifting payer preferences.
June 10, 2026
Labetalol and Nexterone Supply Update: What IV Cardiovascular Buyers Need to Know
Updated October 2026. FDA lists no current shortage for labetalol, amiodarone, nicardipine or diltiazem, but Baxter and Pfizer report 100 mg/20 mL labetalol constraints into 2027 and Baxter reports Nexterone 360 mg/200 mL as limited.
